Correction: Identification of patients at risk for poor survival among those with normal skeletal muscle mass: a multicenter retrospective validation study in gastric cancer - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Recognizing Patients with Normal Skeletal Muscle Mass at Increased Risk for Poor Survival in Gastric Cancer: A Multicenter Retrospective Validation Study

  • By

  • Ryota Matsui

  • Kazuyoshi Yamamoto

  • Yoshiro Yukawa

  • Masayoshi Terayama

  • Yukinori Kurokawa

  • Daisuke Ichikawa

  • Yoshitomo Yanagimoto

  • Takashi Oshima

  • Souya Nunobe

  • Takashi Kamei

  • Hiroya Takeuchi

  • Yoshihiro Nabeya

  • Masaki Kaibori

  • Naoki Hiki

  • Hidetoshi Eguchi

  • Yuichiro Doki

  • August 21, 2026

Share

Correction: Recognizing Patients with Normal Skeletal Muscle Mass at Increased Risk for Poor Survival in Gastric Cancer

Overview

This correction addresses the institutional affiliation errors for authors Hidetoshi Eguchi and Yuichiro Doki. The correct affiliation is the Department of Gastroenterological Surgery at The University of Osaka’s Graduate School of Medicine.

Background

Reduced skeletal muscle mass is associated with poor outcomes in gastric cancer patients, particularly following gastrectomy.

Data Highlights

No numerical or trial data is presented in the correction article.

Key Findings

  • The correction clarifies the correct institutional affiliation for two authors.
  • Reduced skeletal muscle mass is linked to unfavorable postoperative outcomes in gastric cancer.
  • Identification of patients with normal muscle mass but at risk for poor survival is crucial.
  • Standardized nutrition and muscle assessment are emphasized in recent guidelines for gastrointestinal oncology.
  • Recent evidence links body composition with outcomes in gastric cancer.

Clinical Implications

Accurate author affiliations are essential for the integrity of scientific literature.

Conclusion

This correction serves to ensure proper attribution of authorship.

Related Resources & Content

  1. Hidetoshi Eguchi, Yuichiro Doki, Gastric Cancer, 2026 -- Correction: Recognizing Patients with Normal Skeletal Muscle Mass at Increased Risk for Poor Survival in Gastric Cancer
  2. Skeletal Muscle Index Serves as a Standalone Indicator for Early Recurrence in Non-Obese Patients with Colon Cancer
  3. Muscle Mass and Sarcopenia Do Not Serve as Prognostic Indicators for Outcomes Following Esophagectomy in Cancer Patients
  4. Gastric Cancer — Sentinel Node-Based Function-Preserving Gastrectomy Mitigates Osteosarcopenia in Gastric Cancer Patients
  5. GLIM consensus approach to diagnosis of malnutrition: A 5‐year update - PMC
  6. The impact of preoperative skeletal muscle mass index-defined sarcopenia on postoperative complications and survival in gastric cancer: An updated meta-analysis - PubMed
  7. Prognostic values of myosteatosis for overall survival in patients with gastric cancers: A meta-analysis with trial sequential analysis - ScienceDirect

Original Source(s)

Related Content